COVID-19 trials registries data warehouse

https://clinicaltrials.gov/show/NCT04597034

Olynka Vega Vega, MD

olynkavega@hotmail.com

2020-10-22

Unknown

RCT

Randomized

Parallel

Blind label

single-center

Treatment

inclusion criteria: patients aged ≥ 18 years old. a diagnosis of a confirmed, defined by a positive rt-pcr for sars cov-2, or suspected covid-19 disease, with suggestive findings on a chest ct scan. patients on mechanical ventilation. the presence of an informed consent signed by the next of kin. patients with kdigo aki stage 2: defined by a rise in creatinine 2-2.9 times baseline and/or a urinary output less than 0.5 ml/kg/hr for 12 hours, with failure after a furosemide stress test. the use of vasopressor, any dose. complete medical history and complete laboratories.

chronic kidney disease kdigo stage 4, 5, or 5d. next of kin unwilling or patient unwilling to participate. patients with a life expectancy of fewer than 72 hours according to the attending physician criteria. patients older than 75 years. patients with sofa > 11. patients with severe liver failure.

2

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

18

75

Mexico

Critical disease at enrollment

8: Critical disease at enrollment

35

Primary outcome:

None

Not reported

[{"arm_notes": "", "treatment_id": 82, "treatment_name": "An69-oxiris", "treatment_type": "Life support", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]